ENTRANCE PHARMACEUTICALS
&
RESEARCH CENTER
INTRODUCTION
VISION
To be the Premium Provider of quality pharmaceutical products.
MISSION
To meet the pharmaceutical needs of the sub-region by using innovative
approaches to deliver premium quality products through our highly trained
and dedicated staff in a qualified premise.
VALUES
Quality Focus
Customer Satisfaction
Respect
Collaboration
Integrity
ENTRANCE- A COMMERCIAL /ACCESS PARTNER
OF CHOICE
Our strength as a commercial access partner lies in :
OUR MANUFACTURING PLANTS
Our New facility established in 2013.
With 2 separate dedicated plants (a Beta lactam plant and a Non-beta
Lactam plant)
We have Installed, Excess capacity (current utilization 60%) this we believe
offers a prospecting partner a good capacity to come make money through
contract manufacturing.
Have capacity for the manufacture of a wide range of Non-sterile dosage
forms :
liquid preparations
Dry powder for suspension ,
oral powder (sachets)
Tablets
Capsules
NEW ADDITION ON NON-BETA BLOCK
Ointment/creams
Suppository
ENTRANCE- A COMMERCIAL /ACCESS PARTNER OF
CHOICE
◦ MARKET ACESS
LOCAL SALES
Entrance is not new on the distribution market as we distribute our products on
the local market through Tobinco Pharmaceuticals Ltd ( the marketing
Subsidiary for the Tobinco Group of companies of which Entrance belong) a
leading pharmaceutical distributor in Ghana with over 20 years track record as
the strategic key to access you need in Ghana.
Tobinco Pharmaceuticals currently has a track record of selling 20% of Ghana's
generic drugs market with distribution outlets and Networks all across Ghana.
EXPORT MARKET
Entrance offers access to 11 countries within the West African Sub-region most
of which are francophone countries.
We are a partner of choice for timely exports to the sub- region shortening the
long shipment lead time required in exporting from a factory in Europe and
Asia.
Our membership of the free zone provides us the benefits :
To export not less than 70% of products.
All Import and Exports by Entrance are exempted from value added tax and
import /export duties giving us good leverage for competitive pricing on the
export markets.
Established distribution outlets with local distribution network / local Agents in
the various foreign markets we operate.
Participating and wining several foreign government Tenders.
REGIONAL PRESENCE IN AFRICA
ENTRANCE-A TECHNICAL PARTNER OF CHOICE
QUALITY
Have controlled quality systems in place to guarantee the quality of
products are not compromised.
Have submitted ourselves to series of quality audits by several authorities
including:
The Food and Drug Authority , Ghana
Direction de la Pharmacie of Cote d’Ivoire
NDA of Uganda
Latest audit By USP as part of roadmap for WHO prequalification by 2020.
Obtained Category B rating during UNIDO GMP Assessment
ISO 9001:2015 certified (attained certification in September 2017).
◦ QUALITY ASSURANCE TEAM
Have a strong independent Quality Assurance Team with the Quality
Assurance Head who has previous experience in EU, TGA & WHO GMP
certified facilities. A guarantee for no compromise on Quality.
◦ PRODUCT DEVELOPMENT TEAM
Entrance prides in a strong product Development Team with track record of
81 branded generic products developed and registered in the first 4 years of
operation.
Have the Technical skill to handle all R & D technicalities in relation to the
access of technology transfer / development of the products of our strategic
partner timely.
CORPORATE GROWTH STRATEGY
◦ Entrance has an Aggressive market expansion plan to:
Increase our market share in the growing Generic and originator space
in Africa by :
Introduce at least 10 Branded generics each year
seek strategic partnership(s) to manufacture and distribute originator
brands through technology transfer from foreign companies who will
either license these products to us or are willing to sell us product
Dossier or engage us through contract manufacturing.
To increase our export drive by:
Getting our products Registered in 15 new countries by 2023.
Strategic access into new markets through increased investment into
Market Research.
Securing distribution outlets in all operating countries to facilitate
rapid access on new markets.
TYPE OF STRATEGIC PARTNERSHIP
◦ In line with our Corporate strategy, we seek strategic partners who want
access into the west African markets to make money out of the growing
generic and originator market space. Types of partnership we seek are:
Contract manufacturing.
Sale of Product Dossier to enable us manufacture and distribute the
partners originator brands in Ghana and the sub-region of Africa.
Product Divestiture
Sale of ownership rights of partners product(s) to Entrance
Pharmaceuticals and Research Centre giving us the right to freely
produce, sell and market their originator product or branded generic(s)
in Ghana and the sub-region of Africa.
CONCLUSION
◦ Entrance Pharmaceuticals & Research Centre your partner of choice for
strategic pharma business in Ghana and the sub-region of Africa.
